Free Trial

TNF Pharmaceuticals (TNFA) Competitors

$1.22 -0.01 (-0.80%)
(As of 01:59 PM ET)

TNFA vs. AWH, TRIB, VRAX, CDIO, BMRA, MYMD, NAVB, IDXX, LNTH, and NEOG

Should you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Aspira Women's Health (AWH), Trinity Biotech (TRIB), Virax Biolabs Group (VRAX), Cardio Diagnostics (CDIO), Biomerica (BMRA), MyMD Pharmaceuticals (MYMD), Navidea Biopharmaceuticals (NAVB), IDEXX Laboratories (IDXX), Lantheus (LNTH), and Neogen (NEOG). These companies are all part of the "diagnostic substances" industry.

TNF Pharmaceuticals vs.

TNF Pharmaceuticals (NASDAQ:TNFA) and Aspira Women's Health (NASDAQ:AWH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, community ranking, media sentiment, risk, dividends and valuation.

9.6% of TNF Pharmaceuticals shares are owned by institutional investors. Comparatively, 12.2% of Aspira Women's Health shares are owned by institutional investors. 1.2% of TNF Pharmaceuticals shares are owned by company insiders. Comparatively, 4.3% of Aspira Women's Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Aspira Women's Health had 6 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 6 mentions for Aspira Women's Health and 0 mentions for TNF Pharmaceuticals. Aspira Women's Health's average media sentiment score of 0.26 beat TNF Pharmaceuticals' score of 0.00 indicating that Aspira Women's Health is being referred to more favorably in the news media.

Company Overall Sentiment
TNF Pharmaceuticals Neutral
Aspira Women's Health Neutral

TNF Pharmaceuticals has a beta of 2.17, meaning that its stock price is 117% more volatile than the S&P 500. Comparatively, Aspira Women's Health has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500.

Aspira Women's Health has a consensus target price of $4.40, indicating a potential upside of 494.59%. Given Aspira Women's Health's stronger consensus rating and higher probable upside, analysts plainly believe Aspira Women's Health is more favorable than TNF Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TNF Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aspira Women's Health
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Aspira Women's Health received 14 more outperform votes than TNF Pharmaceuticals when rated by MarketBeat users.

CompanyUnderperformOutperform
TNF PharmaceuticalsN/AN/A
Aspira Women's HealthOutperform Votes
14
20.00%
Underperform Votes
56
80.00%

TNF Pharmaceuticals has a net margin of 0.00% compared to Aspira Women's Health's net margin of -165.07%. Aspira Women's Health's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
TNF PharmaceuticalsN/A -180.71% -84.27%
Aspira Women's Health -165.07%N/A -255.28%

TNF Pharmaceuticals has higher earnings, but lower revenue than Aspira Women's Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TNF PharmaceuticalsN/AN/A-$4MN/AN/A
Aspira Women's Health$9.15M1.30-$16.69M-$1.20-0.62

Summary

Aspira Women's Health beats TNF Pharmaceuticals on 10 of the 14 factors compared between the two stocks.

Get TNF Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TNFA vs. The Competition

MetricTNF PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$3.37M$2.23B$5.10B$8.84B
Dividend YieldN/A0.75%5.04%4.07%
P/E RatioN/A3.9195.1214.22
Price / SalesN/A42.281,217.3088.42
Price / CashN/A14.8239.4936.27
Price / Book0.203.106.976.37
Net Income-$4M$29.98M$118.73M$225.56M
7 Day Performance0.02%-1.06%-1.22%-0.02%
1 Month Performance-25.60%-9.76%-3.07%2.04%
1 Year PerformanceN/A-14.64%32.52%28.00%

TNF Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNFA
TNF Pharmaceuticals
N/A$1.22
-0.8%
N/AN/A$3.37MN/A0.006
AWH
Aspira Women's Health
1.6792 of 5 stars
$0.74
+1.4%
$4.40
+494.6%
-78.5%$11.88M$9.15M-0.64110Analyst Forecast
TRIB
Trinity Biotech
1.8381 of 5 stars
$1.28
-1.5%
N/A-33.5%$9.75M$56.83M-0.58480
VRAX
Virax Biolabs Group
0.2701 of 5 stars
$1.91
+1.6%
N/A-24.8%$6.17M$160,000.000.005
CDIO
Cardio Diagnostics
2.1281 of 5 stars
$0.25
+2.4%
$2.00
+700.0%
-89.0%$5.99M$20,000.000.007
BMRA
Biomerica
0.2078 of 5 stars
$0.32
-1.9%
N/A-64.4%$5.35M$5.41M-0.8860News Coverage
Gap Down
MYMD
MyMD Pharmaceuticals
N/A$1.23
+7.0%
N/A-87.3%$2.92MN/A0.009
NAVB
Navidea Biopharmaceuticals
N/A$0.00
flat
N/A-98.3%$100,000.00$70,000.000.0010
IDXX
IDEXX Laboratories
4.8703 of 5 stars
$414.75
-0.9%
$552.38
+33.2%
-11.5%$33.96B$3.66B40.3711,000Positive News
Gap Down
LNTH
Lantheus
4.601 of 5 stars
$87.91
+1.7%
$122.50
+39.3%
+25.1%$6.11B$1.30B14.64834Positive News
NEOG
Neogen
2.1658 of 5 stars
$14.91
+0.1%
$17.50
+17.4%
-8.5%$3.23B$924.22M-135.452,640

Related Companies and Tools


This page (NASDAQ:TNFA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners